Debate & Analysis
Should we be screening for thyroid dysfunction in patients with type 2 diabetes mellitus?
Rebecca J Ward, Adrian H Heald, Seyi Ogunmekan, Anthony A Fryer and Christopher J Duff
British Journal of General Practice 2018; 68 (667): 94-95. DOI: https://doi.org/10.3399/bjgp18X694793
Rebecca J Ward
Department of Clinical Biochemistry, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent.
Roles: Foundation Year 2 Doctor
Adrian H Heald
School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester; Department of Endocrinology, Salford Royal NHS Foundation Trust, Salford.
Roles: Consultant Endocrinologist and Senior Research Fellow
Seyi Ogunmekan
Furlong Medical Centre, Stoke-on-Trent.
Roles: GP
Anthony A Fryer
Department of Clinical Biochemistry, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent; Institute for Applied Clinical Sciences, Keele University, Stoke-on-Trent.
Roles: Professor of Clinical Biochemistry
Christopher J Duff
Department of Clinical Biochemistry, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent; Institute for Applied Clinical Sciences, Keele University, Stoke-on-Trent.
Roles: Principal Clinical Biochemist and Honorary Lecturer
In this issue
British Journal of General Practice
Vol. 68, Issue 667
February 2018
Should we be screening for thyroid dysfunction in patients with type 2 diabetes mellitus?
Rebecca J Ward, Adrian H Heald, Seyi Ogunmekan, Anthony A Fryer, Christopher J Duff
British Journal of General Practice 2018; 68 (667): 94-95. DOI: 10.3399/bjgp18X694793
Jump to section
More in this TOC Section
Related Articles
Cited By...
Intended for Healthcare Professionals